{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:11:30Z","timestamp":1789877490023,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1136\/ard.2003.019125","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T00:34:22Z","timestamp":1084235662000},"page":"1307-1311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide"],"prefix":"10.1016","volume":"63","author":[{"given":"A","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Granath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sparen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ekbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.019125_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.019125_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener's granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.019125_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ijc.10444","article-title":"Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis","volume":"100","author":"Knight","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1136\/ard.2003.019125_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jnci\/87.7.524","article-title":"Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma","volume":"87","author":"Travis","year":"1995","journal-title":"J Nat Cancer Inst"},{"key":"10.1136\/ard.2003.019125_bib5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM198804213181604","article-title":"Carcinoma of the urinary bladder after the treatment with cyclophosphamide for non-Hodgkins lymphoma","volume":"318","author":"Pedersen-Bjergaard","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.019125_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-91-2-221","article-title":"Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis","volume":"91","author":"Plotz","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.019125_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0049-0172(99)80026-2","article-title":"The incidence of cancer associated with the treatment of rheumatoid arthritis","volume":"29","author":"Beauparlant","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2003.019125_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.1780260618","article-title":"ladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis","volume":"26","author":"Ansher","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.019125_bib9","unstructured":"Socialstyrelsen. Patientregistret. Quality and content. Stockholm: Socialstyrelsen, 1987\u201396,."},{"key":"10.1136\/ard.2003.019125_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/02841868409136026","article-title":"Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978","volume":"23","author":"Mattsson","year":"1984","journal-title":"Acta Radiol Oncol"},{"key":"10.1136\/ard.2003.019125_bib11","first-page":"1","article-title":"Statistical methods in cancer research. Volume II. The design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"key":"10.1136\/ard.2003.019125_bib12","first-page":"247","article-title":"Changes and enhancements through release 6.12. SAS Institute Inc","author":"Cary","year":"1997","journal-title":"SAS\/STAT Software"},{"key":"10.1136\/ard.2003.019125_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutical experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.019125_bib14","unstructured":"Centre for Epidemiology NBoHaW. Cancer Incidence in Sweden, 2001. http:\/\/www.sos.se\/epc (accessed 11 July 2004)."},{"key":"10.1136\/ard.2003.019125_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.019125_bib16","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/0006-2952(79)90222-3","article-title":"Cyclophosphamide cystitis\u2014identification of acrolein as the causative agent","volume":"28","author":"Cox","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1136\/ard.2003.019125_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000052494","article-title":"Bladder cancer","volume":"39","author":"Brandau","year":"2001","journal-title":"Eur Urol"},{"key":"10.1136\/ard.2003.019125_bib18","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0022-5347(01)65395-3","article-title":"Cyclophosphamide associated bladder cancer\u2014a highly aggressive disease: Analysis of 12 cases","volume":"156","author":"Fernandes","year":"1996","journal-title":"J Urol"},{"key":"10.1136\/ard.2003.019125_bib19","first-page":"397","article-title":"p53 mutations in cyclophosphamide-associated bladder cancer","volume":"7","author":"Khan","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ard.2003.019125_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D","article-title":"Wegener's granulomatosis associated with renal cell carcinoma","volume":"42","author":"Tatsis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.019125_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780400424","article-title":"Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus","volume":"40","author":"Mellemkjaer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.019125_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","article-title":"Malignancy following treatment of rheumatoid arthritis with cyclophosphamide","volume":"83","author":"Baker","year":"1987","journal-title":"Am J Med"},{"key":"10.1136\/ard.2003.019125_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/art.1780380815","article-title":"Effects of cyclophosphamnide on the delelopment of malignancy and on long term survival of patients with rheumatoid arthritis","volume":"38","author":"Radis","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.019125_bib24","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0022-5347(01)63185-9","article-title":"Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide","volume":"159","author":"De","year":"1998","journal-title":"J Urol"},{"key":"10.1136\/ard.2003.019125_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.1780310402","article-title":"Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis","volume":"31","author":"Stillwell","year":"1988","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724401349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724401349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.019125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:28:57Z","timestamp":1737545337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724401349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0003496724401349"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.019125","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.019125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}